Compare Kyndryl Holdings Inc (KD) vs Upstart Holdings Inc (UPST) Price & Performance

Kyndryl Holdings (KD) trades at $11.88, up 3.76% today, showing recent volatility amid mixed technical signals. The company reported positive net income of $252 million in 2025, marking a significant turnaround from prior losses, though revenue has declined from $18.3B in 2022 to $15.1B. Recent news highlights Kyndryl's strategic focus on AI, including the launch of an innovation lab and acquisition of Healthcare IT Leaders to drive growth.

Outlook remains cautious with analyst consensus leaning Hold (71% of ratings) and a $14.67 price target suggesting moderate upside. Key risks include declining revenue trends and competitive pressures in IT services, while opportunities lie in AI-driven modernization contracts and improved profitability. Investors should weigh the turnaround progress against execution risks in a challenging market.

Upstart Holdings trades at $24.19, up 0.71% with bearish technical signals despite recent partnership expansions. The company achieved profitability in 2025 with $1.02B revenue and $53.6M net income, though recent quarters show earnings misses. Valuation ratios remain elevated with P/E of 46.52 and P/S of 2.1, while analyst consensus targets $39.50 with mixed sentiment.

The stock faces near-term pressure from technical weakness and earnings volatility, but long-term potential exists through AI-driven lending expansion and new auto/HELOC partnerships. Key risks include credit market sensitivity, rising debt levels, and competitive fintech landscape. Current price near recent lows presents opportunity for patient investors despite operational cash flow challenges.